 |
|
Recommendation for use of diphtheria and tetanus toxoids and acellular pertussis, inactivated poliovirus, Haemophilus influenzae type b conjugate, and hepatitis B vaccine in infants
Hye-Kyung Cho, Su Eun Park, Yae-Jean Kim, Dae Sun Jo, Yun-Kyung Kim, Byung-Wook Eun, Taek-Jin Lee, Jina Lee, Hyunju Lee, Ki Hwan Kim, Eun Young Cho, Jong Gyun Ahn, Eun Hwa Choi,
Clin Exp Pediatr. 2021;64(12):602-607. Published online 2021 Jun 8 DOI: https://doi.org/10.3345/cep.2021.00507
|
|
Citations to this article as recorded by
 The global regulatory landscape for combined vaccines: A comparative case study of registration strategies for diphtheria-tetanus-pertussis-containing vaccines.
Xiangchuan He, Yiwen Pu, Zeyu Li, Shitong Huan, Yue Yang
Vaccine.2025; 54: 127017. CrossRef Innovations, Challenges, and Future Prospects for Combination Vaccines Against Human Infections
Munazza Fatima, Kee-Jong Hong
Vaccines.2025; 13(4): 335. CrossRef Promoting higher-valent pediatric combination vaccines in China: challenges and recommendations for action
Jiuling Li, Shu Chen, Edwin Asturias, Shenglan Tang, Fuqiang Cui
Infectious Diseases of Poverty.2024;[Epub] CrossRef Changes in vaccination practices among infants after the introduction of DTaP-IPV/Hib combination vaccines
Hee-Jin Kim, Suvin Park, Na-Young Jeong, Nam-Kyong Choi
Vaccine: X.2024; 18: 100484. CrossRef
|